postburn endotoxic phase, iloprost improved hDO 2 and hVO 2 (140% and 79%, respectively; P Ͻ 0.05 vs. nontreated group, ANOVA).
Conclusions:
Postburn prostacyclin treatment appears to have no beneficial effects on hepatic perfusion early postburn. However, during the late postburn endotoxic phase, prostacyclin seems to significantly improve hepatic total blood flow and oxygenation. In addition, prostacyclin treatment attenuated burn-and endotoxininduced portal hypertension. T he prognosis of extensively burned patients is dependent on the presence of sepsis and/or multiple organ failure. The splanchnic organs are considered to be one of the key components in the pathogenesis of such complications. 1, 2 Disturbances in organ blood flow are suggested to play a pivotal role in the development of progressive organ dysfunction. 3 While restoration of optimal perfusion is essential in reducing both initial ischemia-induced injury and subsequent progressive metabolic and structural derangement, further cell deterioration might occur following reperfusion. 4 The data of our previous studies in a porcine model showed that thermal injury has a selective vasoconstrictive effect on the hepatic arterial circulation. Moreover, a subsequent insult (endotoxemia) was found to induce a significant hepatic ischemia and reperfusion injury, associated with an inadequate hepatic oxygen delivery and a pathologic supplydependent hepatic oxygen consumption. 5, 6 Endogenous prostacyclin is known to be a local mediator of microcirculatory tissue perfusion and metabolism and is of major importance in maintaining splanchnic perfusion after different endogenous vasoconstrictive stimuli, both in animals and in humans. 7, 8 In both septic animals 9 and patients after mesenteric traction during major abdominal surgery, 10 the endogenous release of prostacyclin proved to play a crucial role in maintaining splanchnic perfusion.
In this study, we examined the hypothesis that the stable prostacyclin analogue iloprost beneficially influences the hepatic hemodynamics and thereby improves tissue perfusion and oxygenation in a burn/endotoxin porcine model.
MATERIALS AND METHODS
The following experimental protocols were approved by the Animal Care and Use Committee of the University of Texas Medical Branch (ACUC # 90-09-103).
Eighteen female mini-pigs, weighing between 20 and 25 kg, were prepared surgically 5 days before the experiment. After an overnight fast, the pigs were anesthetized with intramuscular ketamine (10 mg/kg) and mechanically ventilated with 2% to 2.5% halothane after endotracheal intubation, as previously described. 11 A subcostal incision was performed. Transit time ultrasonic flow probes (4 -10 mm, Transonic Systems Inc., Ithaca, NY) were placed on the common hepatic artery and the portal vein; 6.5-Fr catheters were positioned in the superior mesenteric vein and the left hepatic vein. A Witzel jejunostomy was also performed using a 12-Fr Foley catheter. The abdomen was closed in layers.
After surgery, the animals were kept in recovery slings for 24 hours, then placed in runs for 5 days with free access to food and water. On the day of the experiment, the animals were reanesthetized, and through a neck incision an arterial catheter was placed via the right common carotid artery into the abdominal aorta. A Swan-Ganz thermal dilution catheter (model 93 A-131-5F, American Edwards Laboratories, Anasco, PR) was positioned in the pulmonary artery via the right jugular vein. A 12-Fr Foley catheter was inserted in the urinary bladder.
The animals were kept in slings for monitoring. Throughout the study, all animals received enteral feeding (Osmolite) at 25 mL/h and nothing per os. Baseline data were collected after complete recovery from anesthesia.
The pigs were randomized into three groups:
1. The burn/lipopolysaccharide (LPS) group (n ϭ 6) had a 40% total body surface area (TBSA) third-degree flame burn under general anesthesia, as described before. 11 The pigs were resuscitated according to the Parkland formula and received lactated Ringer's solution, 4 mL/kg per %TBSA burn, starting immediately after the burn, half of which was given in the first 8 hours postburn and the remainder in the following 16 hours. Eighteen hours after burn, 100 g/kg Escherichia coli LPS (0111:B4; Difco, Detroit, MI) was intravenously administered. During the second day of the experiment, the burned animals received lactated Ringer's solution at 3.5 mL/m 2 burned area and 2 mL/kg per hour for daily maintenance. 2. The sham group (n ϭ 6) had a sham burn under anesthesia. Eighteen hours later, the animals received the diluent (0.9% NaCl) used for the endotoxin. Lactated Ringer's solution was administered at 2 mL/kg per hour for daily maintenance.
3. The treatment group (n ϭ 6) underwent the same procedure as the burn/LPS group, except for the administration of prostacyclin analogue iloprost (Ilomedin, Schering, AG, Germany) intravenously at 20 ng/kg per minute, immediately after burn.
Mean arterial (MAP), central venous (CVP), and portal venous (PVP) pressures were measured using transducers (P231D, Statham Gould, Oxnard, CA) that were connected to an Electronic Medicine Honeywell Recorder (Honeywell Inc., Pleasantville, NY) for electronic calculation of mean pressures. Cardiac output (CO) was determined by the thermal dilution technique, using a Swan-Ganz catheter and a CO computer (model 9520, American Edwards Laboratories).
Hepatic arterial blood flow (HABF) and hepatic portal venous blood flow (PVBF) were measured with transit time ultrasonic flow probes, connected to a T101 ultrasonic meter (Transonic Systems Inc., Ithaca, NY).
Systemic and hepatic hemodynamics were measured and blood samples were drawn for determinations of arterial, mixed venous, and hepatic blood gases at baseline and 14 consecutive time points, starting 1 hour after burn. At the end of the 42 hours, the animals were anesthetized with 10 mg/kg intravenous ketamine and killed with 5 mL intravenous saturated KCl.
The data are presented as mean Ϯ SEM. Within-group analysis was performed by the analysis of variance (ANOVA) for repeated measurements with the Dunnet post hoc test. Between-groups analysis was performed by ANOVA for factorial analysis with the Bonferroni post hoc test. P values of Ͻ0.05 were considered statistically significant. 
RESULTS

Systemic Hemodynamics
Baseline hemodynamic measurements were similar in all groups. All animals survived the study period. Throughout the experiment, sham animals maintained their systemic (Figs. 1 and 2) and hepatic (Figs. 3 and 4) hemodynamics within baseline range.
Thermal injury reduced CO to 72% of baseline level during the first hour (Fig. 1) . By the second hour postburn, a hyperdynamic phase began with an increase in CO to 139% of baseline. This increase was associated with a concomitant fall in the systemic vascular resistance, whereas SVRI decreased to 81% of baseline ( Fig. 1 ). There were no significant differences in MAP and CVP between the three groups ( Fig. 2) .
Following administration of LPS, a typical biphasic response was observed. After a marked drop of CO to 64% of baseline level, a hyperdynamic period began to be manifest 8 hours postendotoxin ( Fig. 1 ). At this time point, SVRI dropped to 76% of baseline. MAP showed a 27% decrease immediately after LPS infusion in both burn/LPS groups ( Fig. 2) . During the further post-LPS course, no significant differences were noticed between groups in MAP and CVP. Iloprost treatment attenuated to a certain extent the alteration in systemic circulation occurring after burn and LPS administration (Figs. 1 and 2).
Hepatic Hemodynamics Hepatic Arterial Circulation
During the first 4 hours postburn, HABF was significantly reduced to approximately 61% of baseline level (Fig.  3 ). This fall in HABF was associated with a 2.5-fold increase in HAVR as early as 1 hour postburn (Fig. 5) .
Iloprost-treated animals showed a 1.8-fold increase in HAVR following thermal insult (Fig. 5 ). HABF showed a significant reduction in HABF of approximately 38% of baseline level in iloprost-treated animals. The alteration in hepatic arterial hemodynamic parameters lasted for the whole postburn phase in the iloprost-treated group. Hepatic arterial hemodynamic measurements recovered completely in all nontreated animals to baseline values at 18 hours postburn.
Administration of LPS to burned animals resulted in a biphasic response of hepatic hypoperfusion and reperfusion. The second insult resulted in a significant hepatic arterial vasoconstriction with a 15-fold increase of HAVR during the first hour post-LPS.
Correspondingly, HABF decreased significantly to 22% of baseline during the same time of maximum increase of HAVR (Figs. 3 and 5) . After an initial recovery of HABF to baseline values 6 hours post-LPS, a marked elevation (148% of baseline) was noticed during the following 6 hours.
Burned animals treated with iloprost maintained baseline level during the next 24 hours after the second insult (LPS). Iloprost treatment attenuated significantly the hepatic arterial vasoconstriction caused by the administration of LPS to burned animals, as HAVR did not increase but remained within baseline range to the end of the study (Figs. 3 and 5 ).
Hepatic Portal Circulation
During the first 4 hours postburn, PVBF showed an increase, reaching 130% of baseline at 2 hours postburn (Fig.  4) . The increased PVBF was associated with a moderate decrease in HPVR (68% of baseline) during the same time period (Fig. 6 ). PVP showed a 16% increase 1 hour postburn and declined thereafter to baseline level during the next 4 hours postburn (Fig. 7) . In contrast, animals treated with iloprost showed a moderate decrease in their postburn PVBF of approximately 20% of base line values (Fig. 4) . HPVR in the treatment group increased to 161% of baseline value during the first 4 hours postburn (Fig. 6 ). PVP did not show any changes in iloprost-treated animals during the early postburn phase (Fig. 7) .
Portal hemodynamic measurements showed a recovery to baseline values at 18 hours postburn in all animals (Figs. 4, 6, and 7).
The second insult yielded significant alterations in the portal circulation, lasting for a prolonged time period. HPVR 
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showed a 3.6-fold increase during the first 8 hours following LPS administration (Fig. 6 ). During this early septic phase, a significant portal hypertension was noticed, whereas measured PVP was elevated to approximately 156% of baseline values (Fig. 7) . PVBF showed a biphasic response after LPS administration. During the first 8 hours post-LPS, PVBF decreased to approximately 45% of baseline (Fig. 4) . After a transit recovery to baseline, a hyperdynamic phase with an elevation of PVBF to 141% of baseline began at 30 hours (12 hours post-LPS) and remained until the end of the study period (Fig. 4) . During this late septic period, HPVR was decreased to 61% of baseline and PVP was stable at baseline level (Figs. 6 and 7) . Iloprost treatment significantly attenuated the impact of the second insult (LPS) on portal hemodynamics in burned animals. In contrast to nontreated animals, HPVR in the treated group showed for a short period of 2 hours an increase of 1.8-fold, followed by a steady period of 22 hours at baseline level (Fig. 6 ). Iloprost treatment ameliorated the LPS-induced portal ischemia and reperfusion insult in burned animals, as PVBF showed after a moderate decrease of 21% at 2 hours post-LPS a steady increase within baseline range during the rest of the study period (Fig. 4) . Portal hypertension did not occur after LPS administration to burned animals treated with iloprost. PVP remained within baseline range (Fig. 7) .
Systemic Oxygen Delivery and Consumption
After an initial reduction during the first 2 hours postburn, DO 2 and VO 2 showed a marked increase during the following 6 hours postburn (Fig. 8) . Both DO 2 and VO 2 were elevated in the iloprost treatment group during the first 8 hours postburn. The second insult (LPS) yielded a significant drop in DO 2 during the first 2 hours. VO 2 remained unchanged at this time point. During the post-LPS hyperdynamic phase, both DO 2 and VO 2 were increased. Animals treated with iloprost remained baseline levels post-LPS (Fig. 8) .
Hepatic Oxygen Delivery and Consumption
During the first 4 hours postburn, hDO 2 and hVO 2 showed a significant drop to approximately 63% of baseline (Fig. 9) . Iloprost treatment did not have any beneficial effects on hDO 2 and hVO 2 after thermal injury. Indeed, both hDO 2 and hVO 2 were reduced to approximately 61% during the entire postburn period (Fig. 9) .
Administration of LPS resulted in a significant reduction in hDO 2 to a level of 12% of baseline during the first 2 hours post-LPS and remained as low as 56% of baseline at 4 hours post-LPS (Fig. 9 ). Postburn treatment with iloprost prevented this impact of LPS, as hDO 2 increased 40% above the postburn level for 2 hours and then remained within baseline range. hVO 2 showed a similar pattern, whereas a significant decrease of 21% of baseline values was calculated during the first 2 hours post-LPS, followed by a 67% increase at 8 hours post-LPS. Animals receiving iloprost remained baseline levels post-LPS (Fig. 9) .
DISCUSSION
There is compelling experimental evidence that the amplified reaction of the primed inflammatory response sys- 
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Prostacyclin Effects on Hepatic Perfusion After Burn and Sepsis tem of burn patients to a subsequent insult, initiated by bacteria and their byproducts (endotoxins), is responsible for the typical pathophysiological alterations seen in postinjury sepsis. 12 As the liver appears to have a gate function for endogenous bacteria and their endotoxins, it appears that impairment of this hepatic clearance function may potentiate systemic effects of gut barrier failure by allowing indigenous bacteria or endotoxin to reach the systemic circulation, where they potentiate systemic inflammatory responses. 3 Thermal injury appears to induce a selective vasoconstrictive effect on the hepatic arterial circulation, yielding hepatic ischemia and a reduction of hepatic oxygen delivery. The magnitude of the hepatic response to a second insult (endotoxemia) is magnified and manifested as a pronounced hepatic ischemia and reperfusion episode, associated with an inadequate hepatic oxygen delivery and a pathologic supplydependent hepatic oxygen consumption. 5, 6 A variety of autoregulatory mechanisms are involved in maintaining adequate splanchnic perfusion during periods of low flow. 13 The systemic inflammatory response to severe injuries and/or sepsis encompasses several cellular interactions, leading to the generation of diverse proinflammatory cytokines and vasoactive peptides. The vasoactive metabolite of arachidonic acid, prostacyclin (PGI 2 ), appears to play a pivotal role in the process of mesenteric ischemia following burn or sepsis. In a 25% TBSA burn model, splanchnic vasodilator eicosanoid (PGI 2 ) release was decreased by 50% postburn. Loss of this endogenous splanchnic vasodilator may contribute to ischemia of the splanchnic vascular bed at this critical time period following acute burn injury. 14 We therefore tested whether prostacyclin treatment can improve hepatic perfusion after burn.
Despite its well-known vasodilating effects, iloprost did not have any significant impact on systemic hemodynamic parameters during the postburn phase. This observation is in agreement with previous studies, showing that the dose that was used in this study has no circulatory effects. 15 Unexpectedly, no improvement was noticed in postburn hepatic perfusion in the iloprost treatment group. While the postburn ischemic phase was manifested for only 4 hours in the untreated animals, HABF was reduced during the whole postburn period in the treated group. The finding that postburn prostacyclin treatment resulted in a 1.8-fold increase in HAVR shows that prostacyclin did not exert any vasodilating action at all on the hepatic arterial circulation. A possible explanation for this surprising finding is that the dose we applied in our study was not sufficient to overcome the vasoconstrictive impact of thermal trauma on the hepatic arterial circulation. However, similar schemes of administration and dose of iloprost have been used in previous studies. In those studies, iloprost was found to effectively improve splanchnic circulation. [15] [16] [17] On the other hand, in comparison with the design of our study, the previous experiments were different in three aspects. Iloprost was given in those studies as a pretreatment to examine its effect on intestinal perfusion in sepsis. As iloprost pretreatment was also found to increase liver blood flow in a hyperdynamic model of sepsis, 18, 19 one should conclude that iloprost can apparently enhance hepatic perfusion after certain insults such as endotoxemia, providing that the administration starts before the insult. For obvious reasons, we have chosen in our study to investigate the efficiency of iloprost as a postburn treatment. Little is known about the possible effects of exogenous prostacyclin in the early postburn phase. One study has reported that administration of a prostacyclin analogue did not improve survival after infection in burned mice. 20 The mechanism by which splanchnic blood flow is reduced after thermal injuries involves altered release of arachidonic acid metabolites, resulting in a ratio of vasodilator prostacyclin (PGI 2 ) and vasoconstrictor thromboxane A 2 , favoring the latter. 21 Therefore, it could be argued for that administration of exogenous PGI 2 according to our study protocol, failed in restoring the equilibrium between these vasomediators. Therefore, further studies investigating dose-related effects of PGI 2 analogues and FIGURE 9. Hepatic oxygen delivery (hDO 2 ) and hepatic oxygen consumption (hVO 2 ) showed a significant drop after burn and endotoxin. Iloprost treatment significantly attenuated the impact of only the second insult (LPS). P Ͻ 0.05: *versus baseline, #versus sham, ¥versus treatment group (PGI 2 ). Time of endotoxin administration is indicated by 1.
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the impact of administration of exogenous PGI 2 on the feedback mechanisms in relation to endogenous prostacyclins and other mediators, such as thromboxanes, are warranted to elucidate our results and any possible therapeutic potentials of exogenous prostacyclin during the early phase postburn. Another important finding in our study was the observation of the positive impact of the administration of PGI 2 on hepatic perfusion during the late postburn phase, eg, after the second insult (LPS). The second insult (LPS) yielded a significant elevation in HAVR (15-fold vs. baseline), which was associated with a critical reduction of HABF to 22% of baseline during the first 4 hours after endotoxin. After recovery to baseline, a reperfusion episode followed with an elevation of HABF to 148% of baseline, lasting for a period of 6 hours. On the contrary, HABF and HAVR retained their baseline values during the whole post-LPS phase (24 hours) in burned animals receiving PGI 2 infusion. This beneficial effect of PGI 2 administration as documented in our study is completely in agreement with previous studies investigating the effect of PGI 2 in sepsis. Several experimental studies have reported that PGI 2 can increase splanchnic blood flow in septic animals. 7 In animal studies, exogenous administration of PGI 2 and analogues has been shown to exert beneficial effects on the redistribution of blood flow to the hepatosplanchnic area. 16 Raper et al found that PGI 2 increased liver blood flow in a hyperdynamic model of sepsis. 18 More importantly, Trager et al observed in a hyperdynamic endotoxic pig model that iloprost not only increased liver blood flow but also attenuated the endotoxin-induced metabolic alterations as reflected by a blunted decrease in liver lactate consumption and increase in hepatic venous lactate/pyruvate ratio. 19 However, in contrast with our study, in all these previous studies the effect of PGI 2 administration was solely studied in hyperdynamic endotoxic models. To date, no studies have been conducted to investigate the possible actions of prostacyclin treatment on hepatic perfusion during the period of septic complications following thermal injuries. The findings of our study clearly show that postburn prostacyclin treatment is beneficial in maintaining adequate hepatic perfusion during the late postburn endotoxic phase. The explanation of the paradoxical effects of iloprost during the endotoxic postburn phase in comparison with the early postburn period might be that different pathways or interactions with other mediators are involved in these different processes. Another explanation might be that the effect of prostacyclin on HABF is dose related under different pathologic events such as burn and sepsis. More studies on this area are certainly needed to clarify the fundamentals of these conflicting data.
Both burn and endotoxin had a striking impact on hepatic oxygenation. A pathologic flow-dependent hVO 2 response was observed, with a pronounced and prolonged hypoxic period. The first 4 hours postburn were marked by a significant decrease in hDO 2 and hVO 2 . Administration of LPS to burned animals led to a significant reduction in both hDO 2 and hVO 2 (12% and 21% of baseline, respectively). This early decreased hVO 2 indicates the inability of the liver to compensate inadequate oxygen delivery by increasing oxygen extraction, resulting in tissue hypoxia. The development of flow-dependent liver hypoxia was shown before in a septic shock pig model and was reflected in a decrease in liver lactate turnover (increased liver lactate release) during late sepsis. 22 In agreement with previous data, administration of prostacyclin in our burn/sepsis model was associated with enhanced hepatic oxygen delivery and consumption. In a porcine model of septic shock, iloprost tended to attenuate the reduction in liver oxygen delivery. 16 In a hyperdynamic endotoxic pig model, iloprost was found to significantly attenuate the endotoxin-induced derangements of cellular energy metabolism as reflected by the diminished progressive decrease in hepatic lactate uptake rate. 19 The experience with prostacyclin in patients with sepsis is more limited. Lehmann et al observed that prostacyclin increased the rate of disappearance of indocyanine green, a factor influenced by both liver blood flow and function, indicating improvement in liver function. 23 Recently, in patients with septic shock, iloprost was reported to increase splanchnic blood flow and shift oxygen utilization from the energy requiring de novo glucose production rate to other oxygen-demanding metabolic pathways. 24 However, this beneficial effect of iloprost on hepatic oxygenation was only noticed during the late endotoxic postburn phase. In parallel to the effect of prostacyclin on HABF, iloprost failed to improve hepatic oxygenation during the early postburn phase. The consistent effect of prostacyclin on DO 2 and VO 2 after both burn and endotoxin in comparison with its differential impact on hDO 2 and hVO 2 may argue for its selective range of action.
Interesting was the observation that administration of prostacyclin in this study not only altered HABF but also PVBF. The response of the HABF to burn was unrelated to changes in portal circulation. An early postburn hepatic arterial vasoconstriction was found to occur prior to changes in portal circulation (1 hour vs. 2 hours postburn), demonstrating the relative independence of hepatic arterial response in relation with other splanchnic blood flow. Postburn treatment with iloprost was found to ameliorate to a certain extent the impact of burn on PVBF. The function of PVBF as the major intrinsic regulator of hepatic arterial tone is known as the hepatic arterial buffer response. 25 This buffer function appears to depend on portal blood flow washing away local concentrations of adenosine from the area of arterial resistance. The similar biphasic pattern of PVBF and HABF after the second insult (LPS) clearly indicates a loss of the hepatic arterial buffer response, as noticed in previous studies. 6, 26 Despite the marked reduction in PVBF during the first 8 hours after endotoxin, HABF showed a significant decrease Prostacyclin Effects on Hepatic Perfusion After Burn and Sepsis for a period of 6 hours. On the contrary, PVBF in iloprosttreated animals remained steady within baseline values during the whole period after endotoxin. This observation together with the finding that iloprost had exert the same effects on HABF during the same period demonstrates that iloprost was able to increase the total hepatic blood flow during the late postburn endotoxic phase. The exact pathways by which prostacyclin interferes with the different components of the hepatic circulation, and any possible interaction with other local mediators, remain to be delineated. The marked portal hypertension seen in the postburn endotoxemic period may account for the occurrence of bacterial translocation and contribute to the previously reported phenomenon of endotoxin-induced bacterial translocation. 27 Portal hypertension initiated by endotoxin has also been shown to induce hepatic microcirculatory disturbance, which may cause liver injury. 28 Administration of prostacyclin to burned animals resulted in reducing PVP and subsequently attenuating portal hypertension during the late postburn endotoxemia. This specific effect of prostacyclin could be of clinical importance, as postburn administration of prostacyclin may reduce the incidence of hepatic injuries and bacterial translocation in the septic phase.
CONCLUSION
Postburn treatment with prostacyclin appears to have specific, but phase-dependent, effects on hepatic perfusion and oxygenation. The results presented in this study suggest that prostacyclin as applied in our model does not have any beneficial effects in preventing hepatic ischemia and reperfusion injury in the early postburn phase. Quite the opposite, postburn prostacyclin treatment was found to significantly enhance hepatic blood flow and oxygen supply during the late postburn septic phase. In addition, postburn prostacyclin administration seems to attenuate burn-and endotoxin-induced portal hypertension. Because of the possible clinical significance of these data, further studies in this area are warranted.
